Metabolism of cystathionine, N-monoacetylcystathionine, perhydro-1,4-thiazepine-3,5-dicarboxylic acid, and cystathionine ketimine in the liver and kidney of D,L-propargylglycine-treated rats

被引：2

作者：

Zhang, JY ^{[1
]}

Zhang, MY ^{[1
]}

Ma, DS ^{[1
]}

Sugahara, K ^{[1
]}

Kodama, H ^{[1
]}

机构：

[1] Kochi Med Sch, Dept Chem, Nankoku, Kochi 783, Japan

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 1998年 / 47卷 / 10期

关键词：

D O I：

10.1016/S0026-0495(98)90329-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Experimental cystathioninuria was induced by injection of D,L-propargylglycine in rats. The novel cystathionine metabolites, N-monoacetylcystathionine (NAc-cysta), perhydro-1,4-thiazepine-3,5-dicarboxylic acid (PHTZDC), and cystathionine ketimine (CK), were identified previously in the urine of patients with cystathioninuria and D,L-propargylglycine-treated rats. In this study, we identified these compounds in the liver and kidney of D,L-propargylglycine-treated rats using liquid chromatography-mass spectrometry with an atmospheric pressure chemical ionization interface system (LC/APCI-MS) and an amino acid analyzer. The metabolism of these compounds in the liver and kidney of D,L-propargylglycine-treated rats was also studied. PHTZDC, NAc-cysta, and CK were accumulated in the rat tissues in proportion to the content of cystathionine after D,L-propargylglycine administration. The concentrations of these compounds in the liver were higher than those in the kidney, and these compounds reached maxima earlier in the liver than in the kidney.

引用

页码：1233 / 1238

页数：6

共 29 条

[1] ACETYLENIC ENZYME INACTIVATORS - INACTIVATION OF GAMMA-CYSTATHIONASE, IN-VITRO AND IN-VIVO, BY PROPARGYLGLYCINE [J].